Using the Larsen index to assess radiographic progression in rheumatoid arthritis
- PMID: 10648052
Using the Larsen index to assess radiographic progression in rheumatoid arthritis
Abstract
To describe the Larsen index and its strengths and weaknesses. I reviewed the original publication, a number of published modifications, tests of reproducibility, and some clinical studies that have used the index. The Larsen index is essentially a grading of erosion severity that has satisfactory reproducibility for use in groups of patients. The Larsen index can clearly distinguish different rates of erosive progression in groups of patients with different characteristics or treatments. Recent studies using the Larsen index have identified clear treatment effects. Difficulty in measuring the success of previous treatments designed to hold back the progression of erosions relates to the inefficacy of those treatments, not insensitivity of the Larsen index.
Similar articles
-
Quantitative assessment of hand radiographs of rheumatoid arthritis: interobserver variation in a multicenter radiographic study.J Orthop Sci. 2003;8(4):467-73. doi: 10.1007/s00776-003-0676-0. J Orthop Sci. 2003. PMID: 12898296
-
Comparison of the original and the modified Larsen methods and the Sharp method in scoring radiographic progression in early rheumatoid arthritis.J Rheumatol. 1998 Jun;25(6):1063-6. J Rheumatol. 1998. PMID: 9632064
-
Assessing radiographic status of rheumatoid arthritis: introduction of a short erosion scale.J Rheumatol. 2000 Sep;27(9):2090-9. J Rheumatol. 2000. PMID: 10990218
-
Introduction to reading radiographs by the Scott modification of the Larsen method.J Rheumatol. 1999 Mar;26(3):740-2. J Rheumatol. 1999. PMID: 10090193 Review.
-
[Quantitative analysis of radiologic progression in rheumatoid arthritis: controversies and perspectives].Radiol Med. 1997 Mar;93(3):174-84. Radiol Med. 1997. PMID: 9221406 Review. Italian.
Cited by
-
Prognostic factors of radiographic progression in early rheumatoid arthritis: a two year prospective study after a structured therapeutic strategy using DMARDs and very low doses of glucocorticoids.Clin Rheumatol. 2007 Jul;26(7):1111-8. doi: 10.1007/s10067-006-0462-4. Epub 2006 Nov 16. Clin Rheumatol. 2007. PMID: 17109060 Free PMC article. Clinical Trial.
-
Novel Chimeric Peptides Based on the Enolase Peptide Antigen (CEP-1) Bearing Three Post-Translational Modifications (Citrullination, Homocitrullination and Acetylation) for Determining the Diagnosis and Severity of Rheumatoid Arthritis.Int J Mol Sci. 2024 Oct 3;25(19):10654. doi: 10.3390/ijms251910654. Int J Mol Sci. 2024. PMID: 39408982 Free PMC article.
-
Peptides Bearing Multiple Post-Translational Modifications as Antigenic Targets for Severe Rheumatoid Arthritis Patients.Int J Mol Sci. 2021 Dec 10;22(24):13290. doi: 10.3390/ijms222413290. Int J Mol Sci. 2021. PMID: 34948087 Free PMC article.
-
Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis.Ann Rheum Dis. 2005 Dec;64(12):1731-6. doi: 10.1136/ard.2005.035691. Epub 2005 May 5. Ann Rheum Dis. 2005. PMID: 15878904 Free PMC article.
-
Patient initiated outpatient follow up in rheumatoid arthritis: six year randomised controlled trial.BMJ. 2005 Jan 22;330(7484):171. doi: 10.1136/bmj.38265.493773.8F. Epub 2004 Nov 16. BMJ. 2005. PMID: 15546895 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Medical